The Coronavirus Vaccination WHO Strategic Consultative Group (SAGE) on vaccination to the issuance of recommendation provided for the use of vaccinations inactivated COVID-19, Sinovac-CoronaVac, developed by Sinovac / China National Pharmaceutical Group.
The recommendations provided and the information document is available online. The countries Peuvent are referring to the Feuille de route for the prioritization of the WHO and the Cadre of the value of the WHO to obtain the council’s person minors of on the priority of the group’s Cables.
Coronavirus Vaccination Strategic Advisory Group of Experts:
Who Should Vaccination First?
- While Covid vaccine supplies are limited, health workers at high risk of exposure and older people should be prioritized for vaccination.
- Countries can refer to the WHO Prioritization Roadmap and the WHO Values
- Framework as guidance for their prioritization of target groups.
- The vaccine is not recommended for persons younger than 18 years of age,
- pending the results of further studies in that age group.
Who Else Can Take The Covid-19 Vaccination?
Vaccination recommends for persons with commodities that have been identifying as increasing the risk of severe COVID-19, including obesity, cardiovascular disease, and respiratory disease. The vaccine can offer to people who had COVID-19 in the past. However, available data shows that symptomatic reinfection is unlikely in these persons for up to 6 months after natural infection.
- Persons living with human immunodeficiency virus (HIV) or who immunocompromise are at higher risk of severe COVID-19 disease.
- Such persons did not include in the clinical trials informing SAGE’s review, but given this is a non-replicated vaccine,
- Persons living with HIV or who are immunocompromised and part of the recommended group for vaccination may be vaccinated.
Should Pregnant Women Be Vaccination?
The available data on the Sinovac-CoronaVac (COVID-19) vaccine in pregnant women is insufficient to assess either vaccine efficiency or possible vaccine-associated risks in pregnancy. Then the effectiveness of the Sinovac-CoronaVac (COVID-19) vaccine in pregnant women. Therefore expect to be comparable to that observed in non-pregnant women of similar age. In the interim, WHO recommends the use of the Sinovac-CoronaVac vaccine in pregnant women.
When the benefits of vaccination to the pregnant woman outweigh the potential risks. To help pregnant women make this assessment. Because they should be provided with information about the risks of COVID-19 in pregnancy; the likely benefits of vaccination in the local epidemiological context; and the current limitations of safety data in pregnant women.
Recommended Dosage Of Coronavirus Vaccine:
SAGE recommends the use of the Sinovac-CoronaVac vaccine as 2 doses (0.5 ml) given intramuscularly. WHO recommends an interval of 2–4 weeks between the first and second dose of the Corona vaccine. If the administration of the second dose is delay beyond 4 weeks to take the earliest possible opportunity.